NASDAQ: XPAXXpac Acquisition Corp Stock
$10.30+0.00 (+0%)
Updated Jun 5, 2023
XPAX Price
$10.30
Fair Value Price
N/A
Market Cap
$282.75M
52 Week Low
$9.71
52 Week High
$10.60
P/E
60.59x
P/B
-19.17x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$4.66M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$297k
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
XPAX Overview
XPAC Acquisition Corporation is a "blank check" company formed to effect mergers, amalgamation, share exchanges, asset acquisitiosn, share purchases, reorganizations, or other similar combinations with one or more businesses. The company was incorporated in 2021 and is based in New York, NY.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XPAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XPAX ($10.30) is trading above its intrinsic value of $0.95, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XPAX is poor value based on its earnings relative to its share price (60.59x), compared to the US market average (53.21x)
P/E vs Market Valuation
XPAX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more XPAX due diligence checks available for Premium users.
Be the first to know about important XPAX news, forecast changes, insider trades & much more!
XPAX News
Valuation
XPAX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
60.59x
Industry
42.09x
Market
53.21x
XPAX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
XPAX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
XPAX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-19.17x
Industry
-27.35x
XPAX's financial health
Profit margin
Revenue
$0.0
Net Income
$2.5M
Profit Margin
0%
XPAX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$225.3M
Liabilities
$14.9M
Debt to equity
-1.01
XPAX's short-term liabilities ($5.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XPAX's long-term liabilities ($9.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XPAX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XPAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$34.0k
Investing
$0.0
Financing
$0.0
XPAX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
XPAX vs Shell Company Stocks
Xpac Acquisition Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.